Maryland 2025 Regular Session

Maryland House Bill HB356

Introduced
1/16/25  

Caption

State Prescription Drug Benefits - Retirees

Impact

The implications of HB 356 are substantial, as it not only repeals existing programs designed to assist retirees with prescription costs but also modifies the eligibility framework under which these benefits are provided. The discontinuation of the Maryland State Retiree Prescription Drug Coverage Program, along with associated assistance programs, risks leaving many retirees without adequately supported prescription drug coverage. The bill seeks to streamline benefits, but it raises questions regarding the accessibility and adequacy of alternative support for those retirees affected by these changes.

Summary

House Bill 356 pertains to the prescription drug benefits for retirees within the State Employee and Retiree Health and Welfare Benefits Program. The bill aims to authorize certain retirees who began their State service before a specific date to retain eligibility for these benefits. However, it introduces significant changes by discontinuing prescription drug benefits for Medicare-eligible retirees who began State service on or after a certain date, in addition to their eligible spouses and dependent children. This removal of benefits is comprehensive and marks a critical shift in how the State supports its retired workforce.

Contention

The bill has sparked notable debate regarding its fairness and the potential consequences for retirees, especially those who heavily rely on prescription medications. Supporters argue that the changes are necessary to reduce fiscal strains on the State's budget and ensure that benefits can be managed more effectively. However, critics highlight the detrimental impact on vulnerable populations among the retirees, arguing that access to medication should be safeguarded. They express concerns that the bill could lead to increased out-of-pocket expenses for many retirees who might struggle without the State's support.

Implementation

Should the bill pass, it will require a transitional period where the Department of Budget and Management will need to implement new guidelines and protocols for retirees seeking assistance or coverage under alternative programs. The bill's stipulation for creating new programs or structures for reimbursement may ease some transitions, but the gap left by the removal of existing benefits remains a key concern for affected retirees.

Companion Bills

MD HB670

Carry Over State Prescription Drug Benefits - Retirees

Similar Bills

MD HB424

Prescription Drug Affordability Board - Authority and Stakeholder Council Membership (Lowering Prescription Drug Costs for All Marylanders Now Act)

MD SB357

Prescription Drug Affordability Board - Authority and Stakeholder Council Membership (Lowering Prescription Drug Costs for All Marylanders Now Act)

MD SB306

Workers' Compensation - Prescription Drug and Pharmaceutical Services - Reimbursements

MD HB813

Maryland Insurance Administration and Maryland Department of Health - Workgroup to Study Pharmacy Benefits Managers

MD HB321

Pharmacy Benefits Managers – Definition of Purchaser and Alteration of Application of Law

MD SB372

Preserve Telehealth Access Act of 2025

MD HB869

Preserve Telehealth Access Act of 2025

MD HB382

Maryland Medical Assistance Program and Health Insurance - Step Therapy, Fail-First Protocols, and Prior Authorization - Prescription to Treat Serious Mental Illness